4//SEC Filing
Aggarwal Sumit 4
Accession 0001104659-25-006784
CIK 0001035354other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 5:37 PM ET
Size
7.6 KB
Accession
0001104659-25-006784
Insider Transaction Report
Form 4
Aggarwal Sumit
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-01-24−30,000→ 30,000 total→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2025-01-24+30,000→ 199,930 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001854362
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 5:37 PM ET
- Size
- 7.6 KB